Canadian Patent Office to Grant Merck’s Patent Application for CRISPR Technology – PR Newswire India (press release)
|
Canadian Patent Office to Grant Merck’s Patent Application for CRISPR Technology
PR Newswire India (press release) DARMSTADT, Germany, Oct. 24, 2017 /PRNewswire/ — Merck, a leading science and technology company, today announced that the Canadian Patent Office has issued a “Notice of Allowance” for Merck’s patent application covering the company’s CRISPR … |
|
AbbVie bets on Alzheimer’s immunotherapy with big biotech deal
Reuters The idea of using immunotherapy in Alzheimer’s mirrors the success of immuno-oncology in cancer, where drugs that help the immune system battle tumors are revolutionizing care. Scientists at AbbVie and Alector believe there is growing evidence that … |
|
Canadian Patent Office to Grant Merck’s Patent Application for CRISPR Technology
PR Newswire UK (press release) DARMSTADT, Germany, Oct. 24, 2017 /PRNewswire/ — Merck, a leading science and technology company, today announced that the Canadian Patent Office has issued a “Notice of Allowance” for Merck’s patent application covering the company’s CRISPR … |
|
Canadian Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology
Canada NewsWire (press release) “Our patent portfolio continues to grow worldwide, extending protection for our unique CRISPR technology as we work with the global scientific community to find new treatments for diseases,” said Udit Batra, CEO, MilliporeSigma. “This decision by the … |
TheChronicleHerald.ca |
Dalhousie gene research team seeks international competition gold
TheChronicleHerald.ca What do a porcupine and biofuel have in common? This isn’t a trick question but one that the amazing minds at Dalhousie iGEM have been working on all summer in an effort to bring their best synthetic biology foot forward at this year’s iGEM competition. |
Financial Times |
Alzheimer’s immunotherapy boosted by AbbVie deal
Financial Times AbbVie has signed a deal with a biotech company to develop medicines that encourage the immune system to fight Alzheimer’s, as the drugmaker seeks to replicate an approach that has proven successful in treating cancer. The Chicago-based … A company that’s taking a new approach to tackling Alzheimer’s just landed a $225 million endorsementBusiness Insider UK |
|
Designer babies in the age of CRISPR
McGill Tribune A powerful gene-editing tool, known as CRISPR, has been developing, promising new approaches to treating various illnesses and even modification of children by their parents. Yet, it seems society still hasn’t addressed fears about the possible misuse … |